Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Postural Orthostatic Tachycardia Syndrome 1Mastocytosis 1Leukemia, Myelomonocytic, Chronic 1Intestinal Neoplasms 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1Breast Neoplasms 1Adenoma 1

Interventions

Irinotecan 5Bevacizumab 5Leucovorin 4Fluorouracil 45,10-methylenetetrahydrofolic acid 3Oxaliplatin 2Levoleucovorin 2Drug Therapy 2Cetuximab 2trametinib 1spartalizumab 1repotrectinib 1pralsetinib 1pembrolizumab 1nazartinib 1napabucasin 1encorafenib 1canakinumab 1alectinib 1Tinzaparin 1Radiotherapy 1Pemetrexed 1Ocoxin 1Mass Screening 1KRN-330 1Folfox protocol 1Capecitabine 1Artesunate 1ABT-165 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Intestinal Neoplasms × Mass Screening × Clear all
NCT04640792 2022-05-05

A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy

Magentiq Eye LTD

Phase NA Completed
952 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡